CARE Ratings · NSE: CARERATING · BSE: 534804

Q4 FY23 results · Jan–Mar 2023

CARE Ratings reported revenue from operations of ₹77.51 crore (up 17.7% from Q4 FY22) and net profit of ₹20.15 crore (down 13.5% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations77.5165.88+17.7%62.15+24.7%
Other income10.377.18+44.5%11.59−10.5%
Total income87.8873.06+20.3%73.73+19.2%
Profit before tax34.0927.39+24.4%22.68+50.3%
Net profit for the period20.1523.31−13.5%16.31+23.5%
Attributable to shareholders of the company19.7022.90−14.0%15.95+23.5%
EPS, basic (₹)6.607.72−14.5%5.38+22.7%
Net margin (%)26.035.426.2
Standalone · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations68.0559.54+14.3%54.55+24.7%
Other income10.127.39+36.9%11.03−8.2%
Total income78.1766.94+16.8%65.58+19.2%
Profit before tax35.1534.18+2.8%27.29+28.8%
Net profit for the period25.8628.92−10.6%21.40+20.8%
EPS, basic (₹)8.719.75−10.7%7.22+20.7%
Net margin (%)38.048.639.2
Consolidated
Filed with BSE
18 May 2023, 13:18 IST
Board meeting
11 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
18 May 2023, 13:18 IST
Board meeting
11 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE